Appella; Daniel H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Appella; Daniel H..The latest application filed is for "cgap-pna multivalent peptide nucleic acid ligand display".

Company Profile

1.10.15

Appella; Daniel H. - Rockville MD
Appella; Daniel H. - Evanston IL
Appella, Daniel H. - Boston MA
Appella; Daniel H. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclopentane-peptide nucleic acids for qualitative and quantitative detection of nucleic acids Grant 10,457,978 - Appella , et al. Oc	2019-10-29
cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY App 20170002355 - Appella; Daniel H. ; et al.	2017-01-05
Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens Grant 9,156,778 - Appella , et al. October 13, 2	2015-10-13
Cyclopentane-peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids App 20150218617 - Appella; Daniel H. ; et al.	2015-08-06
Beta-amino acids Grant 8,772,450 - Gellman , et al. July 8, 2	2014-07-08
Programmable Self-assembled Nanostructures Based On Sidechain-modified Pna For The Multivalent Display Of Ligands App 20140148500 - Appella; Daniel H.	2014-05-29
Beta-amino Acids App 20130023644 - Gellman; Samuel H. ; et al.	2013-01-24
Cross-coupled Peptide Nucleic Acids For Detection Of Nucleic Acids Of Pathogens App 20120322053 - Appella; Daniel H. ; et al.	2012-12-20
Cross-Coupled Peptide Nucleic Acids for Detection of Nucleic Acids of Pathogens App 20120107794 - Appella; Daniel H. ; et al.	2012-05-03
Compounds and related methods for mutant p53 reactivation Grant 7,829,304 - Appella , et al. November 9, 2	2010-11-09
Synthesis Of Trans-tert-butyl-2-aminocyclopentylcarbamate App 20100120031 - Appella; Daniel H. ; et al.	2010-05-13
Compounds and Related Methods for Mutant p53 Reactivation App 20080206805 - Appella; Daniel H. ; et al.	2008-08-28
Compounds and related methods for mutant p53 reactivation Grant 7,329,775 - Appella , et al. February 12, 2	2008-02-12
Beta-amino acids App 20070123709 - Gellman; Samuel H. ; et al.	2007-05-31
Compounds and related methods for mutant p53 reactivation App 20050245616 - Appella, Daniel H. ; et al.	2005-11-03
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems App 20050065349 - Buchwald, Stephen L. ; et al.	2005-03-24
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems Grant 6,787,655 - Buchwald , et al. September 7, 2	2004-09-07
.beta.-polypeptide foldamers of well-defined secondary structure Grant 6,613,876 - Gellman , et al. September 2, 2	2003-09-02
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems App 20030125563 - Buchwald, Stephen L. ; et al.	2003-07-03
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems Grant 6,465,664 - Buchwald , et al. October 15, 2	2002-10-15
Beta-amino acids App 20020037997 - Gellman, Samuel H. ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.